HCID 68154117, compound → HCID 67111534, compound

Participants

Reaction Steps

Phenylmethyl 4-(3-oxo-5-{[4-(1H-pyrazol-1-yl)phenyl]methyl}-3,5-dihydro-2H-pyrazolo[4,3-c]quinolin-2-yl)piperidine-1-carboxylate (Example 511, 25 mg, 0.045 mmol) was dissolved in ethyl acetate, treated with palladium(II) hydroxide on carbon (2.5 mg, 0.1 wt equiv), sparged under an atmosphere of hydrogen (1 atm) and stirred for 1 hour at ambient temperature. The mixture was sparged under an atmosphere of nitrogen, filtered through a pad of Celite and the filtrate was concentrated in vacuo. The residue was purified by silica gel gradient chromatography (100:0 to 80:20; dichloromethane:methanol), providing the titled compound: 1H-NMR (400 MHz, CDCl3) δ 8.83 (1H, s), 8.38-8.36 (1H, m), 7.89 (1H, d, J=2.4 Hz), 7.71 (1H, d, J=1.8 Hz), 7.69 (2H, d, j=8.7 Hz), 7.52-7.43 (3H, m), 7.30-7.26 (3H, m), 6.46 (1H, m), 5.59 (2H, s), 4.61 (1H, m), 3.58-3.50 (2H, m), 3.01-2.96 (2H, m), 2.65-2.57 (2H, m), 2.13-2.05 (2H, m) ppm; low resolution mass spectrometry (ES+) m/z 424.9 [(M+H)+; calculated for C25H25N6O: 425.2].

Provenance & Evidence